tamibarotene has been researched along with Angiogenesis, Pathologic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Iida, S; Ishida, T; Komatsu, H; Kuwano, M; Kuwano, T; Nakao, S; Ono, M; Sanda, T; Shudo, K; Ueda, R | 1 |
| Ashino, H; Morita, I; Murota, S; Oikawa, T; Okayasu, I; Shudo, K | 1 |
2 other study(ies) available for tamibarotene and Angiogenesis, Pathologic
| Article | Year |
|---|---|
Antimyeloma effects of a novel synthetic retinoid Am80 (Tamibarotene) through inhibition of angiogenesis.
Topics: Animals; Benzoates; Cell Division; Cell Line, Tumor; Cell Movement; Coculture Techniques; Cornea; Down-Regulation; Endothelium, Vascular; Hematopoietic Stem Cells; Humans; Interleukin-6; Male; Mice; Mice, Inbred BALB C; Multiple Myeloma; Neovascularization, Pathologic; NIH 3T3 Cells; Phosphorylation; Receptors, Interleukin-6; Receptors, Vascular Endothelial Growth Factor; Retinoids; Tetrahydronaphthalenes; Umbilical Veins; Vascular Endothelial Growth Factor A | 2005 |
Three novel synthetic retinoids, Re 80, Am 580 and Am 80, all exhibit anti-angiogenic activity in vivo.
Topics: Animals; Benzoates; Cell Differentiation; Chick Embryo; Dose-Response Relationship, Drug; Neovascularization, Pathologic; Tetrahydronaphthalenes | 1993 |